Feb 06, 5:51 PMCanopy Growth completed a $150M recapitalization extending debt maturities to 2031, ended Q3 with $371M cash and $146M net cash, and reported Q4 FY2025 results with a revenue beat but EPS miss (revenue $54.5M, non-GAAP EPS -$0.13), while Q3 FY2026 showed flat $75M revenue, 4% cannabis net revenue growth, a narrower net loss, a reduced $3M adjusted EBITDA loss, and a reiterated FY2027 positive adjusted EBITDA target; on its Q3 call, it said the proposed MTL Cannabis acquisition is expected to be gross-margin and EBITDA accretive with a CAD 40–50M cash outlay and a targeted near-term blended gross margin in the mid- to high-30% range.
Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, International Markets Cannabis, Storz and Bickel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The International Markets Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
